These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8676446)

  • 1. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
    Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
    J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
    Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
    J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
    Awasthi S; Lubinski JM; Friedman HM
    Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T; Gianopulos KA; Nicola AV
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
    Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
    J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
    J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.
    Lubinski J; Wang L; Mastellos D; Sahu A; Lambris JD; Friedman HM
    J Exp Med; 1999 Dec; 190(11):1637-46. PubMed ID: 10587354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
    Lubinski JM; Jiang M; Hook L; Chang Y; Sarver C; Mastellos D; Lambris JD; Cohen GH; Eisenberg RJ; Friedman HM
    J Virol; 2002 Sep; 76(18):9232-41. PubMed ID: 12186907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.
    Hidaka Y; Sakai Y; Toh Y; Mori R
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():915-21. PubMed ID: 1849974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection.
    Judson KA; Lubinski JM; Jiang M; Chang Y; Eisenberg RJ; Cohen GH; Friedman HM
    J Virol; 2003 Dec; 77(23):12639-45. PubMed ID: 14610186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
    Gerber SI; Belval BJ; Herold BC
    Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evasion by herpes simplex virus type 1, strategies for virus survival.
    Friedman HM
    Trans Am Clin Climatol Assoc; 2003; 114():103-12. PubMed ID: 12813914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
    Harris SL; Frank I; Yee A; Cohen GH; Eisenberg RJ; Friedman HM
    J Infect Dis; 1990 Aug; 162(2):331-7. PubMed ID: 2165106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
    McNearney TA; Odell C; Holers VM; Spear PG; Atkinson JP
    J Exp Med; 1987 Nov; 166(5):1525-35. PubMed ID: 2824652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
    Friedman HM; Glorioso JC; Cohen GH; Hastings JC; Harris SL; Eisenberg RJ
    J Virol; 1986 Nov; 60(2):470-5. PubMed ID: 3021981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo.
    Lubinski JM; Wang L; Soulika AM; Burger R; Wetsel RA; Colten H; Cohen GH; Eisenberg RJ; Lambris JD; Friedman HM
    J Virol; 1998 Oct; 72(10):8257-63. PubMed ID: 9733869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral interference with antibody and complement.
    Lubinski J; Nagashunmugam T; Friedman HM
    Semin Cell Dev Biol; 1998 Jun; 9(3):329-37. PubMed ID: 9665870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.